Similar articles for PMID: 35705203

Year	Number of Results
1969	1
1981	1
1988	1
1989	2
1990	1
1992	1
1994	1
1998	2
1999	1
2006	1
2007	2
2008	1
2009	2
2010	1
2011	2
2012	5
2013	3
2014	2
2015	7
2016	2
2017	7
2018	12
2019	9
2020	9
2021	14
2022	14
2023	2
2024	0

1

Serotonergic psychedelic treatment for obesity and eating disorders: potential expectations and caveats for emerging studies.

Borgland SL, Neyens DM. Borgland SL, et al. J Psychiatry Neurosci. 2022 Jun 15;47(3):E218-E221. doi: 10.1503/jpn.220090. Print 2022 May-Jun. J Psychiatry Neurosci. 2022. PMID: 35705203 Free PMC article. No abstract available.

2

Complexities of psychedelics for therapeutic use in obesity and eating disorders.

Reichelt A. Reichelt A. J Psychiatry Neurosci. 2022 Oct 25;47(5):E366. doi: 10.1503/jpn.220135-l. Print 2022 Sep-Oct. J Psychiatry Neurosci. 2022. PMID: 36283696 Free PMC article. No abstract available.

3

Perspectives on psychedelic treatment and research in eating disorders: a web-based questionnaire study of people with eating disorders.

Harding F, Seynaeve M, Keeler J, Himmerich H, Treasure J, Kan C. Harding F, et al. J Integr Neurosci. 2021 Sep 30;20(3):551-560. doi: 10.31083/j.jin2003059. J Integr Neurosci. 2021. PMID: 34645088 Free article.

4

Psychedelic-Assisted Therapy for People with Eating Disorders.

Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS. Gukasyan N, et al. Curr Psychiatry Rep. 2022 Dec;24(12):767-775. doi: 10.1007/s11920-022-01394-5. Epub 2022 Nov 14. Curr Psychiatry Rep. 2022. PMID: 36374357 Review.

5

Nourishing the Spirit: Exploratory Research on Ayahuasca Experiences along the Continuum of Recovery from Eating Disorders.

Lafrance A, Loizaga-Velder A, Fletcher J, Renelli M, Files N, Tupper KW. Lafrance A, et al. J Psychoactive Drugs. 2017 Nov-Dec;49(5):427-435. doi: 10.1080/02791072.2017.1361559. Epub 2017 Sep 12. J Psychoactive Drugs. 2017. PMID: 28895501

6

Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder.

Spriggs MJ, Kettner H, Carhart-Harris RL. Spriggs MJ, et al. Eat Weight Disord. 2021 May;26(4):1265-1270. doi: 10.1007/s40519-020-01000-8. Epub 2020 Sep 8. Eat Weight Disord. 2021. PMID: 32895801

7

Clinical pharmacology of eating and not eating.

Melotto S. Melotto S. Curr Opin Pharmacol. 2014 Feb;14:1-5. doi: 10.1016/j.coph.2013.09.015. Epub 2013 Oct 19. Curr Opin Pharmacol. 2014. PMID: 24565004 Review.

8

Role of ghrelin in the pathophysiology of eating disorders: implications for pharmacotherapy.

Cardona Cano S, Merkestein M, Skibicka KP, Dickson SL, Adan RA. Cardona Cano S, et al. CNS Drugs. 2012 Apr 1;26(4):281-96. doi: 10.2165/11599890-000000000-00000. CNS Drugs. 2012. PMID: 22452525 Review.

9

Serotoninergic system: therapeutic implications in obesity.

Finer N. Finer N. Acta Clin Belg Suppl. 1992;14:47-51. doi: 10.1080/17843286.1992.11718276. Acta Clin Belg Suppl. 1992. PMID: 1604961 Review. No abstract available.

10

Identification of new drug targets and biomarkers related to obesity and eating disorders: an approach based on reward deficit and addiction.

Alguacil LF, Salas E, González-Martín C. Alguacil LF, et al. Curr Pharm Des. 2011;17(5):462-70. doi: 10.2174/138161211795164158. Curr Pharm Des. 2011. PMID: 21375484 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

94 results

Results by year